| Active ingredient (INN) | Aztreonam |
|---|---|
| Brand names | Azactam, Azactam For, AZACTAM aztreonam |
| ATC level 5 | J01DF01 |
| ATC level 4 | J01DF |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Bristol-Myers Squibb Australia Pty Ltd, Hospira, Inc. |
| Registrations on file | 3 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| AZACTAM aztreonam | 1g | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| Aztreonam | 1g/1 | injection | 🇺🇸 US | Hospira, Inc. | Active |
| Aztreonam | 2g/1 | injection | 🇺🇸 US | Hospira, Inc. | Active |